Sawada O - Search Results

1

Duration of Vascular Endothelial Growth Factor Suppression after Intravitreal Injection of Faricimab in Macaque Eyes.

Matsumoto R, Obata S, Kakinoki M, Sawada O, Kawamoto I, Murase M, Ohji M. Matsumoto R, et al. Among authors: sawada o. J Ocul Pharmacol Ther. 2024 Oct 2. doi: 10.1089/jop.2024.0138. Online ahead of print. J Ocul Pharmacol Ther. 2024. PMID: 39358308

2

Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes.

Obata S, Kakinoki M, Sawada O, Kawamoto I, Murase M, Ohji M. Obata S, et al. Among authors: sawada o. J Ocul Pharmacol Ther. 2023 Apr;39(3):225-228. doi: 10.1089/jop.2022.0160. Epub 2023 Mar 6. J Ocul Pharmacol Ther. 2023. PMID: 36862540

3

Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab.

Sawada O, Kawamura H, Kakinoki M, Ohji M. Sawada O, et al. Graefes Arch Clin Exp Ophthalmol. 2008 Oct;246(10):1379-81. doi: 10.1007/s00417-008-0874-8. Epub 2008 Jun 26. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 18581130

4

Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.

Sawada O, Kawamura H, Kakinoki M, Sawada T, Ohji M. Sawada O, et al. Among authors: sawada t. Arch Ophthalmol. 2007 Oct;125(10):1363-6. doi: 10.1001/archopht.125.10.1363. Arch Ophthalmol. 2007. PMID: 17923544

5

Interleukin-10 and interleukin-6 in aqueous humor during treatment of vitreoretinal lymphoma with intravitreally injected methotrexate.

Kawamura H, Yasuda N, Kakinoki M, Sawada T, Sawada O, Ohji M. Kawamura H, et al. Among authors: sawada t, sawada o. Ophthalmic Res. 2009;42(3):172-4. doi: 10.1159/000230879. Epub 2009 Jul 31. Ophthalmic Res. 2009. PMID: 19648778

6

Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes.

Miyake T, Sawada O, Kakinoki M, Sawada T, Kawamura H, Ogasawara K, Ohji M. Miyake T, et al. Among authors: sawada t, sawada o. Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1606-8. doi: 10.1167/iovs.09-4140. Epub 2009 Oct 29. Invest Ophthalmol Vis Sci. 2010. PMID: 19875666

7

Vascular endothelial growth factor in the aqueous humour in eyes with myopic choroidal neovascularization.

Sawada O, Kawamura H, Kakinoki M, Sawada T, Ohji M. Sawada O, et al. Among authors: sawada t. Acta Ophthalmol. 2011 Aug;89(5):459-62. doi: 10.1111/j.1755-3768.2009.01717.x. Epub 2010 Jan 22. Acta Ophthalmol. 2011. PMID: 20102348 Free article.

8

Aqueous vascular endothelial growth factor after intravitreal injection of pegaptanib or ranibizumab in patients with age-related macular degeneration.

Sawada O, Miyake T, Kakinoki M, Sawada T, Kawamura H, Ohji M. Sawada O, et al. Among authors: sawada t. Retina. 2010 Jul-Aug;30(7):1034-8. doi: 10.1097/IAE.0b013e3181ce74c8. Retina. 2010. PMID: 20616682

9

Negative correlation between aqueous vascular endothelial growth factor levels and axial length.

Sawada O, Miyake T, Kakinoki M, Sawada T, Kawamura H, Ohji M. Sawada O, et al. Among authors: sawada t. Jpn J Ophthalmol. 2011 Jul;55(4):401-404. doi: 10.1007/s10384-011-0027-1. Epub 2011 May 24. Jpn J Ophthalmol. 2011. PMID: 21607685

10

Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys.

Kakinoki M, Sawada O, Sawada T, Saishin Y, Kawamura H, Ohji M. Kakinoki M, et al. Among authors: sawada t, sawada o. Invest Ophthalmol Vis Sci. 2012 Aug 24;53(9):5877-80. doi: 10.1167/iovs.12-10164. Invest Ophthalmol Vis Sci. 2012. PMID: 22836776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters